Noom Coach for Bariatric Surgery
Randomized Trial of an Innovative Smartphone Application for Bariatric Surgery
1 other identifier
interventional
50
1 country
1
Brief Summary
The prevalence of overweight in America is a national public health crisis. As more people consider bariatric surgery for the treatment of severe obesity, it is imperative to identify factors influencing surgical outcomes. Technology, particularly the Noom Coach platform, offers a unique opportunity to improve standard interventions utilized in bariatric surgery programs. This study plans to test the efficacy of the Noom Coach platform on patients' adherence behaviors and psychosocial factors compared to standard care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable obesity
Started Dec 2017
Shorter than P25 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 30, 2017
CompletedStudy Start
First participant enrolled
December 5, 2017
CompletedFirst Posted
Study publicly available on registry
December 29, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 9, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 9, 2018
CompletedMay 22, 2023
May 1, 2023
11 months
October 30, 2017
May 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in adherence to dietary recommendations
Change in adherence to recommendations provided within pre-bariatric surgery program will be assessed using the ASA-24 interview. The interview is a 24-hr recall of all food and drink consumed. This interview will serve as the basis for measuring the adherence to dietary recommendations.
Baseline and 8 weeks
Change in adherence to physical activity recommendations (Activity Tracker)
Change in adherence to physical activity recommendations will be measured using information collected from each participants activity tracker (FitBit). The activity tracker records number of steps taken each day and any physical activity performed.
Ongoing
Change in adherence to physical activity recommendations (IPAQ)
Change in adherence to physical activity recommendations will also be measured using self reported physical activity using the International Physical Activity Questionnaire (IPAQ) The IPAQ is a 27- item questionnaire that assesses physical activity over the past week as a part of everyday activity, activity as a part of work, and activity as recreation. Scores include both minutes and days spent doing physical activity with higher scores indicating more time spent doing these activities. The measure can be scored categorically (low, moderate, high) or continuously using a defined scoring protocol.
Baseline and 8 weeks
Secondary Outcomes (3)
Eating Disorder Examination Questionnaire (EDE-Q)
Baseline and 8 weeks
Depression Anxiety Stress Scales (DASS)
Baseline and 8 weeks
Short Form-36 Health Survey (SF-36)
Baseline and 8 weeks
Study Arms (2)
Noom Coach for Bariatric Health
EXPERIMENTALSelf-monitoring will be conducted through Noom Coach for Bariatric Health, and individuals will receive a specialized set of instructions on how to use the app.
Usual Care
NO INTERVENTIONThe control group will be a "usual care" condition in which participants are free to seek any assistance for their bariatric surgery care during the study period.
Interventions
Noom Coach for Bariatric Health offers a sustainable, low-cost, coach-led intervention, and an innovative solution to issues with pre-bariatric surgery weight loss. The intervention will take place over 8 weeks.
Eligibility Criteria
You may qualify if:
- Enrolled in: the Mount Sinai Bariatric Surgery Program and planning to receive a bariatric procedure.
- Between the ages of 18 and 60 at entry to the study.
- Speak English.
You may not qualify if:
- Clinically significant cognitive limitations or history of developmental disability.
- History of neurological disorder or injury.
- Current/lifetime Diagnostic and Statistical Manual of Mental Disorders (DSM-5) serious psychiatric disorder, such as bipolar disorder, schizophrenia, or psychotic disorder.
- Acute suicide risk.
- Current DSM-5 alcohol or substance use disorder.
- Pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Noom Inc.lead
- Icahn School of Medicine at Mount Sinaicollaborator
Study Sites (1)
Noom, Inc.
New York, New York, 10001-5915, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 30, 2017
First Posted
December 29, 2017
Study Start
December 5, 2017
Primary Completion
November 9, 2018
Study Completion
November 9, 2018
Last Updated
May 22, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share